×
Home Current Archive Editorial board
News Contact
Research paper

The role of serum vitamin D concentrations in predicting COVID-19 course and outcome

By
Dunja Božić ,
Dunja Božić

Clinical Centre of Kragujevac , Kragujevac , Serbia

Đorđe Stevanović ,
Đorđe Stevanović

Clinical Centre of Kragujevac , Kragujevac , Serbia

Mina Poskurica Orcid logo ,
Mina Poskurica

Clinical Centre of Kragujevac , Kragujevac , Serbia

Marina Petrović Orcid logo
Marina Petrović

Clinical Centre of Kragujevac , Kragujevac , Serbia

Abstract

Introduction/Aim. The coronavirus disease 2019 (COVID-19) pandemic had significant acute and long-term impact on people's health. As the available literature sources have shown that the premorbid conditions affect the course of COVID-19, we aimed to investigate the role of admission vitamin D concentration to predict the outcome of hospitalized COVID-19 patients. Methods. An observational, prospective cohort study was conducted on 329 COVID-19 patients hospitalized at the University Clinical Centre Kragujevac, between October and December 2021. Within 24 hours of admission, vitamin D level was measured from the peripheral venous blood. Medical history data and socio-demographic characteristics were obtained anamnestically and using Health Information System (COMTRADE, Serbia). Lethal outcome and intensive care unit (ICU) admission were considered primary end-points. Results. The prevalence of hypovitaminosis D on admission in our cohort was 27.7%. Both non-survivors and patients requiring ICU admission more frequently had hypovitaminosis D compared to survivors (42,9% versus 21,0%; p < 0,001) and patients on a standard level of care (31,5% verus 25,3%; p = 0,029). Our research showed that vitamin D concentration < 20 ng/mL was an independent predictor of mortality (aOR 2.142 [95% CI 1.226 - 3.744]). However, hypovitaminosis D upon hospital admission did not show a significant impact on ICU admission. Conclusion. Low vitamin D concentration on admission could be a significant predictor of outcome in hospitalized COVID-19 patients.

References

1.
Shi K, Liu Y, Zhang Q, Ran C ping, Hou J, Zhang Y, et al. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chinese Journal of Integrative Medicine. 2022;28(1):3–11.
2.
Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, et al. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Frontiers in Public Health. 9.
3.
Organisation WH. COVID-19 Clinical Management: Living Guidance. 2021.
4.
Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, et al. MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19. European Journal of Endocrinology. 2020;183(5):R133–47.
5.
Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients. 12(11):3361.
6.
Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 12(7):2097.
7.
Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of <scp>COVID</scp>‐19 severity: A literature review. Reviews in Medical Virology. 2021;31(1):1–10.
8.
Djaharuddin I, Munawwarah S, Nurulita A, Ilyas M, Tabri NA, Lihawa N. Comorbidities and mortality in COVID-19 patients. Gaceta Sanitaria. 2021;35:S530–2.
9.
Name JJ, Souza ACR, Vasconcelos AR, Prado PS, Pereira CPM. Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity. Frontiers in Nutrition. 7.
10.
Kaya MO, Pamukçu E, Yakar B. The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies. Epidemiology and Health. 43:e2021074.
11.
Teshome A, Adane A, Girma B, Mekonnen ZA. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Frontiers in Public Health. 9.
12.
Chen J, Mei K, Xie L, Yuan P, Ma J, Yu P, et al. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs. Nutrition Journal. 2021;20(1).
13.
Borsche L, Glauner B, von Mendel J. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients. 13(10):3596.
14.
Zappulo F, Cappuccilli M, Cingolani A, Scrivo A, Chiocchini ALC, Nunzio MD, et al. Vitamin D and the Kidney: Two Players, One Console. International Journal of Molecular Sciences. 23(16):9135.
15.
Petrelli F, Luciani A, Perego G, Dognini G, Colombelli PL, Ghidini A. Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. The Journal of Steroid Biochemistry and Molecular Biology. 2021;211:105883.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.